Monitoring multidimensional aspects of quality of life after cancer immunotherapy: protocol for the international multicentre, observational QUALITOP cohort study

INTRODUCTION: Immunotherapies, such as immune checkpoint inhibitors and chimeric antigen receptor T-cell therapy, have significantly improved the clinical outcomes of various malignancies. However, they also cause immune-related adverse events (irAEs) that can be challenging to predict, prevent and...

Descripción completa

Detalles Bibliográficos
Autores principales: Vinke, Petra C., Combalia, Marc, de Bock, Geertruida H, Leyrat, Clémence, Spanjaart, Anne Mea, Dalle, Stephane, Gomes da Silva, Maria, Fouda Essongue, Aurore, Rabier, Aurélie, Pannard, Myriam, Jalali, Mohammad S, Elgammal, Amal, Papazoglou, Mike, Hacid, Mohand-Said, Rioufol, Catherine, Kersten, Marie-José, van Oijen, Martijn GH, Suazo-Zepeda, Erick, Malhotra, Ananya, Coquery, Emmanuel, Anota, Amélie, Preau, Marie, Fauvernier, Mathieu, Coz, Elsa, Puig, Susana, Maucort-Boulch, Delphine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151860/
https://www.ncbi.nlm.nih.gov/pubmed/37105689
http://dx.doi.org/10.1136/bmjopen-2022-069090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151860/
https://www.ncbi.nlm.nih.gov/pubmed/37105689
http://dx.doi.org/10.1136/bmjopen-2022-069090

Ejemplares similares